Dianoxyl 20 – Kalpa Pharmaceuticals (INT)

$57.00

Availability: In Stock

METHANDIENONE 20 MG TABS
Drug Class: Androgen; Anabolic Steroid
Composition:
– Active Substance: Methandienone
– Concentration: 20 mg/tab
Presentation: 100 tabs
Manufacturer: Kalpa Pharmaceuticals
Common Name(s): D-Bol, Dianabol, Anabol

Reviews

There are no reviews yet.

Be the first to review “Dianoxyl 20 – Kalpa Pharmaceuticals (INT)”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsDianoxyl 20 - Kalpa Pharmaceuticals (INT) removeMethazone - Methandienone 100 mg. removeWinimed 10mg – Stanozolol – Deus Medical removeArimimed 1mg – Anastrozole – Deus Medical removeLetrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention removeClenomed 40mg – Clenbuterol – Deus Medical remove
Image
Int'l
EU
EU
EU
EU
EU
SKUkalpa-int-027RF-AlphaZone-upline5484101AAS-DM-0-101101AAS-DM-0-114101AAS-HB-0-139101AAS-DM-0-120
Rating
Price$57.00$113.99 $48.00 $60.00 $75.00 $48.00
Stock

Out of stock

AvailabilityOut of stock
Add to cart

Add to cart

Read more

Add to cart

Add to cart

Add to cart

Add to cart

DescriptionMETHANDIENONE 20 MG TABS Drug Class: Androgen; Anabolic Steroid Composition: - Active Substance: Methandienone - Concentration: 20 mg/tab Presentation: 100 tabs Manufacturer: Kalpa Pharmaceuticals Common Name(s): D-Bol, Dianabol, AnabolActive Ingredient: Methandienone 10mg Count: 100Tabs Active Half-life: 5-6 Hours Classification: Anabolic Steroid Acne: Yes Concentration: 10 mg/tab Presentation: 100 Tablets (Total box 1000mg) Dosage: 20-80mg per day over the course of 6-8 weeksActive Ingredient: Stanozolol 10mg Tablet Count: 50 Tablets Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 20-50 Mg/day Acne: Yes Water Retention: No Hbr: Perhaps Hepatoxity: YesActive: (anastrozole) Tabs Molar mass: 293.366 g/mol CAS ID: 120511-73-1 Formula: C17H19N5 Elimination half-life: 46.8 hours Trade name: Arimidex, others Metabolism: Liver (85%)CTIVE INGREDIENT: Letrozole 2.5mg TABLET COUNT: 30 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 2.5-5 MG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO Ship From: EuropeTablet Count: 50 Pills Dose: 80 – 120mcg per day Cycle: 6-8 weeks. Bioavailability: 89–98% (orally) Molar mass: 277.19 Elimination half-life: 36–48 hours Metabolism: Hepatic (negligible)
ContentMethandienone 10mg x 100 tablets Methandienone was used as a stimulating recovery processes, revitalizing, treating burns tools. Today, the use of Methandrostenolone athletes to increase muscle mass.Steroid profile increase in muscle mass due to stimulating the production of protein. A significant part of gaining weight is a persons in the body of water. If you do not take appropriate pharmacological agents, most often occurs the phenomenon of recoil.Letrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature.
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information